Vimarsana
Biggest News Aggregation in the World

Page 6 - Suzanne Winter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Suzanne Winter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Suzanne Winter Today - Breaking & Trending Today

Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023 - Vimarsana News

Accuray Announces Suzanne Winter Selected as One of the Top 50 Healthcare Technology CEOs of 2023

/PRNewswire/ -- The global Accuray Incorporated (NASDAQ: ARAY) team is proud to announce that president and CEO Suzanne Winter has been recognized by The...

Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness - Vimarsana News

Accuray CyberKnife® and TomoTherapy® Platforms Featured in More Than 55 Abstracts Presented at ESTRO 2023, Reinforcing Systems' Versatility, Efficiency and Effectiveness

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO)...

Accuray Reports Fiscal 2023 Third Quarter Financial Results - Vimarsana News

Accuray Reports Fiscal 2023 Third Quarter Financial Results

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2023 ended March 31, 2023. Third Quarter...

The Healthcare Technology Report's Top 25 Women Leaders in Medical Devices of 2023 - Vimarsana News

The Healthcare Technology Report's Top 25 Women Leaders in Medical Devices of 2023

New York, NY (PRWEB) February 15, 2023 -- The Healthcare Technology Report is pleased to announce The Top 25 Women Leaders in Medical Devices of 2023.

Source: prweb.com
Accuray stock rises on Street-beating Q2 - Vimarsana News

Accuray stock rises on Street-beating Q2

Accuray (Nasdaq:ARAY) shares rose this morning on second-quarter results that topped the consensus forecast.